DB
ADMA icon

Danske Bank’s ADMA Biologics ADMA Stock Holding History

Danske Bank’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-500
Closed -$9.12K – 1181
2025
Q4 		$9.12K Hold
500
– – ﹤0.01% 1325
2025
Q3 		$7.33K Hold
500
– – ﹤0.01% 1287
2025
Q2 		$9.11K Hold
500
– – ﹤0.01% 1294
2025
Q1 		$9.92K Sell
500
-25,494
-98% -$441K ﹤0.01% 1079
2024
Q4 		$446K Sell
25,994
-49,702
-66% -$935K ﹤0.01% 917
2024
Q3 		$1.51M Sell
75,696
-38,314
-34% -$596K 0.01% 723
2024
Q2 		$1.27M Sell
114,010
-7,274
-6% -$61K ﹤0.01% 717
2024
Q1 		$800K Buy
+121,284
New +$663K ﹤0.01% 843

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Danske Bank's ADMA Position: Q1 2026 in Review

Danske Bank sold out of ADMA Biologics (ADMA) in Q1 2026, closing a stake of 500 shares — an estimated $9.12K sold.

Danske Bank first reported a position in ADMA in Q1 2024 and held it in 8 quarters. The position peaked at $1.51M in Q3 2024. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Danske Bank reported no remaining ADMA Biologics position as of Q1 2026 after selling out during the quarter.
  • Danske Bank sold 500 ADMA Biologics shares in Q1 2026, an estimated $9.12K.
  • Danske Bank first reported a position in ADMA Biologics in Q1 2024 and held it in 8 quarters.
  • Danske Bank's ADMA Biologics position peaked at $1.51M in Q3 2024.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.